AbbVie
Acronym: ABBV
General Information
Identification Code: 934069612666-51
Website: [object Object]
Entity Form: AbbVie inc.
Registration Category: Companies & groups
Registration Date: 1/20/2014
Last Update: 3/14/2024
EP Accredited Number: 2
Mission & Interests
Goals: AbbVie is a Specialty-focused, research-based biopharmaceutical company focused on developing new products and new ways to help people manage some of the most serious health conditions. We are scientists, researchers, communicators, manufacturing specialists, and regulatory experts.
AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. Since then, Abbott has evolved to become a global healthcare leader, delivering innovative pharmaceutical, nutritional, diagnostic, and medical products to people in more than 150 countries.
On January 1, 2013, AbbVie was founded, a global biopharmaceutical company with the focus and capabilities to address some of the world's greatest health challenges. AbbVie has the stability, resources, expertise, and passion to discover, develop, and bring to market groundbreaking science to solve the biggest health problems that face the world today (...)
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Competition
- Digital economy and society
- Economy, finance and the euro
- Employment and social affairs
- Institutional affairs
- Public health
- Research and innovation
- Single market
- Trade
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: - Pharmaceutical Strategy, and in particular review of the basic pharmaceutical legislation, of the Orphan Medicinal Products Regulation, and of the Paediatric Medicines Regulation
- European Health Data Space
- Industrial Policies and IP Action Plan, and in particular questions around patents, SPC and so on.
- Joint Procurement for medical countermeasures
- Competition in the pharmaceutical sector
- Revision of Medical Device and IVD Regulation
- Urban Waste water Directive
- Packaging and Packaging waste
- European Commission activities around ensuring effective, resilient and sustainable healthcare systems
- Access to Medicines
- Beating cancer plan
Communication Activities: AbbVie has supported a number of roundtables that were hosted by members of the European Parliament and politicla parties, and has also participated in the EU public debate through op-eds that were published in the relevant trade press.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: North Waukegan Road, 1
Post Code: IL 60064
City: North Chicago
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: Square de Meeus 37
City: Brussels
Country: BELGIUM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: Since 2022 and the new interinstitutonal agreement and the guidelines issued in that context, the reporting structure has changed. This led to adding additional employees and their salaries whose activities are now considered in-scope, as well as to counting the membership fees to organization we are members of (which we previously excluded to avoid double reporting).
Membership Information
Members10 Percent: 4
Members25 Percent: 2
Members50 Percent: 0
Members75 Percent: 2
Members: 8
Members F T E: 2.4000000953674316
Structure
Structure Type: Structure
Is Member Of: - ACHIEVE coalition (Associations collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe), which has a secretariat that is run by FIPRA
Organisation Members: - American Chamber of Commerce to the EU
- European Federation of Pharmaceutical Industries and Association (EFPIA)
- EuropaBio – the European Association of Bio-Industries
- Friends of Europe